Reprise Biomedical news
Thanks to those who attended our webinar on Tuesday, January 19th 2021: Reducing Failure Rates in Hiatal and Paraesophageal Hernia Repair – the ‘Achilles Heel’ of Anti-reflux Surgery with Dr. G. Kevin Gillian.
The Florida Chapter, American College of Surgeons, and Reprise Biomedical are pleased to host a FREE Webinar on Tuesday, January 19th, 2021 at 7:00 p.m. EST. ???? Join us for a 45 min presentation followed by a Q&A session on “Reducing Failure Rates in Hiatal and Paraesophageal Hernia Repair – the ‘Achilles Heel’ of Anti-reflux Surgery” with Dr. G. Kevin Gillian. Tune in to learn how Reprise Biomedical’s MiroFlex biologic matrix (formerly MiroMesh)
Reprise Biomedical, Inc., a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology, has successfully completed a $12.5 million private placement and commenced operations as a spin-off from Miromatrix Medical Inc.
Through the spin-off, Miromatrix transferred to Reprise two existing FDA 510(k) cleared, commercially available medical devices – MIROMESH and MIRODERM - as well as all acellu